Combination chemotherapy with intermittent erlotinib and pemetrexed for pretreated patients with advanced non-small cell lung cancer: a phase I dose-finding study
© Minami et al.; licensee BioMed Central Ltd. 2012
Received: 11 January 2012
Accepted: 20 June 2012
Published: 18 July 2012
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting firstname.lastname@example.org.
|11 Jan 2012||Submitted||Original manuscript|
|Resubmission - Version 2|
|Submitted||Manuscript version 2|
|4 Apr 2012||Reviewed||Reviewer Report - Lucio Crinò|
|9 Apr 2012||Reviewed||Reviewer Report - dr atul sharma|
|10 May 2012||Author responded||Author comments - TAKASHI KIJIMA|
|Resubmission - Version 3|
|10 May 2012||Submitted||Manuscript version 3|
|28 May 2012||Author responded||Author comments - TAKASHI KIJIMA|
|Resubmission - Version 4|
|28 May 2012||Submitted||Manuscript version 4|
|20 Jun 2012||Editorially accepted|
|18 Jul 2012||Article published||10.1186/1471-2407-12-296|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting email@example.com. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.